As of Nov 25
| +0.70 / +1.13%|
The 9 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 66.00, with a high estimate of 88.00 and a low estimate of 12.00. The median estimate represents a +5.72% increase from the last price of 62.43.
The current consensus among 11 polled investment analysts is to Hold stock in Isis Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.